SVB Leerink Maintains Outperform on Evolus, Raises Price Target to $20

SVB Leerink analyst Marc Goodman maintains Evolus (NASDAQ:EOLS) with a Outperform and raises the price target from $18 to $20.

SVB Leerink analyst Marc Goodman maintains Evolus (NASDAQ:EOLS) with a Outperform and raises the price target from $18 to $20.

Total
0
Shares
Related Posts
Read More

Reported Late Wednesday, TD SYNNEX Announces Pricing Of Secondary Public Offering Of 4.5M Shares Of Stock At A Price Of $97/Share And Concurrent Share Repurchase Of 900K Shares From The Underwriters Under The Current Existing $1B Share Repurchase Progr…

TD SYNNEX Corporation (NYSE:SNX) ("TD SYNNEX" or the "Company") today announced the pricing of a secondary public offering of 4,500,000 shares of its common stock at a price to the public

SNX